1. Lau Moon Lin M, Robinson PD, Flank J, Sung L, Dupuis LL. The safety of metoclopramide in children: a systematic review and meta-analysis. Drug safety. 2016 Jul;39(7):675-87.
2. Rodnitzky RL. Drug-induced movement disorders in children. InSeminars in Pediatric Neurology 2003 Mar 1 (Vol. 10, No. 1, pp. 80-87). WB Saunders.
3. Dudipala SC, Prashanthi M, Ch LK. Clinical profile of acute drug-induced dystonia in children. Indian Journal of Child Health. 2020 May 26;7(5):220-2.
4. Van Harten PN, Hoek HW, Kahn RS. Acute dystonia induced by drug treatment. Bmj. 1999 Sep 4;319(7210):623-6.
5. Park HW, Kwak JR, Lee JS. Clinical characteristics of acute drug-induced dystonia in pediatric patients. Clinical and Experimental Emergency Medicine. 2017 Sep 30;4(3):133.
6. Yarar C, Yakut A, Carman KB, Sahin S, Kocak O, Ozkan S, et al. Metoclopramide-induced acute dystonia: data from a pediatric emergency unit. Pediatric emergency care. 2021 Sep 1;37(9):e528-33.
7. Menikarachchi L, Jayantha M. Text Mining Analysis of Metoclopramide Reviews: Adverse Effects, Patients’ Perspectives and Off-label Use. Sri Lankan Journal of Health Sciences. 2022 Dec 31;1(2).
8. Fransisca TB, Nanda D, Khoirunnisa R, Leksono AD, Maliha AR, Salsabila NS, et al. Comparison of The Effectiveness of Ondansetron and Metoclopramide in Nausea and Vomiting: Literature Review. Menara Journal of Health Science. 2025 Dec 25;4(4):368-83.
9. Hoffman RJ, Nillas A. Toxidromes and a general approach to poisoning. Archives of disease in childhood. 2025 Sep 1;110(9):681-6.
10. Bateman DN, Rawlins MD, Simpson JM. Extrapyramidal reactions with metoclopramide. Br Med J (Clin Res Ed). 1985 Oct 5;291(6500):930-2.
11. Garone G, Graziola F, Grasso M, Capuano A. Acute movement disorders in childhood. Journal of Clinical Medicine. 2021 Jun 17;10(12):2671.
12. Kulkarni SD, Kothari SR. Pediatric movement disorders and neuromodulation: An overview. Neurology India. 2020 Nov 1;68(Suppl 2):S206-12.
13. Panda PK, Panda P. Nelson Textbook of Pediatrics 22nd International Edition.
14. Rissardo JP, Vora N, Mathew B, Kashyap V, Muhammad S, Fornari Caprara AL. Overview of movement disorders secondary to drugs. Clinics and Practice. 2023 Aug 18;13(4):959-76.
15. Hammami H, Jeddi C, Kilani M, Thabet H. Acute drug-induced dystonia: Emergency department presentation and management. Toxicologie Analytique et Clinique. 2025 Sep 2.
16. Gorodetsky C, Fasano A. Approach to the treatment of pediatric dystonia. Dystonia. 2022 Aug 2;1:10287.
17. Cui L, Guo D, Zhu M, Wang T, Gao A, Xiao J. Incidence, clinical characteristics and related drugs analyzing of drug-induced movement disorders in 102914 inpatients: a retrospective real-world study. Expert Opinion on Drug Safety. 2025 May 5:1-9.
18. Tran H, Sun D. New Advances in US FDA Approved Oncology Drugs from 2015-2023. American Journal of Pharmaceutical Education. 2024 Sep 1;88(9).